End-of-day quote
Qatar Exchange
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
1.919
QAR
|
+0.95%
|
|
+2.07%
|
+7.33%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
18,882
|
31,534
|
25,717
|
26,257
|
26,722
|
22,463
|
Enterprise Value (EV)
1 |
17,133
|
29,983
|
24,264
|
24,054
|
23,897
|
19,356
|
P/E ratio
|
13.5
x
|
26.5
x
|
48.3
x
|
14.1
x
|
15.1
x
|
20.7
x
|
Yield
|
5.32%
|
2.79%
|
1.95%
|
5.26%
|
5.17%
|
4.81%
|
Capitalization / Revenue
|
15.2
x
|
31.3
x
|
39.6
x
|
14
x
|
15
x
|
20.4
x
|
EV / Revenue
|
13.8
x
|
29.8
x
|
37.3
x
|
12.8
x
|
13.4
x
|
17.6
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
22.1
x
|
69.1
x
|
50.3
x
|
19.8
x
|
21.7
x
|
29.6
x
|
FCF Yield
|
4.52%
|
1.45%
|
1.99%
|
5.06%
|
4.6%
|
3.38%
|
Price to Book
|
1.25
x
|
2.07
x
|
1.63
x
|
1.54
x
|
1.53
x
|
1.31
x
|
Nbr of stocks (in thousands)
|
12,563,175
|
12,563,175
|
12,563,175
|
12,563,175
|
12,563,175
|
12,563,175
|
Reference price
2 |
1.503
|
2.510
|
2.047
|
2.090
|
2.127
|
1.788
|
Announcement Date
|
2/17/19
|
2/23/20
|
3/4/21
|
2/21/22
|
2/15/23
|
2/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,244
|
1,006
|
650.1
|
1,877
|
1,783
|
1,099
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,225
|
985.8
|
636.1
|
1,861
|
1,767
|
1,083
|
Operating Margin
|
98.43%
|
98%
|
97.84%
|
99.16%
|
99.09%
|
98.48%
|
Earnings before Tax (EBT)
1 |
1,225
|
989.7
|
532.2
|
1,862
|
1,767
|
1,083
|
Net income
1 |
1,394
|
1,192
|
532.2
|
1,862
|
1,767
|
1,083
|
Net margin
|
112.04%
|
118.45%
|
81.86%
|
99.19%
|
99.09%
|
98.48%
|
EPS
2 |
0.1110
|
0.0948
|
0.0424
|
0.1482
|
0.1407
|
0.0862
|
Free Cash Flow
1 |
775.2
|
433.9
|
482.7
|
1,217
|
1,100
|
654.7
|
FCF margin
|
62.3%
|
43.14%
|
74.25%
|
64.85%
|
61.67%
|
59.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
55.61%
|
36.42%
|
90.7%
|
65.38%
|
62.23%
|
60.47%
|
Dividend per Share
2 |
0.0800
|
0.0700
|
0.0400
|
0.1100
|
0.1100
|
0.0860
|
Announcement Date
|
2/17/19
|
2/23/20
|
3/4/21
|
2/21/22
|
2/15/23
|
2/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,749
|
1,550
|
1,453
|
2,203
|
2,825
|
3,107
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
775
|
434
|
483
|
1,217
|
1,100
|
655
|
ROE (net income / shareholders' equity)
|
9.4%
|
7.86%
|
3.34%
|
11.3%
|
10.3%
|
6.28%
|
ROA (Net income/ Total Assets)
|
5.1%
|
4%
|
2.45%
|
6.94%
|
6.27%
|
3.83%
|
Assets
1 |
27,352
|
29,765
|
21,737
|
26,810
|
28,203
|
28,297
|
Book Value Per Share
2 |
1.200
|
1.210
|
1.250
|
1.360
|
1.390
|
1.360
|
Cash Flow per Share
2 |
0.0100
|
0.0600
|
0.0100
|
0.0100
|
0.1100
|
0.0200
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/19
|
2/23/20
|
3/4/21
|
2/21/22
|
2/15/23
|
2/11/24
|
|
1st Jan change
|
Capi.
|
---|
| +7.33% | 6.56B | | +4.41% | 103B | | +1.20% | 68.41B | | +44.29% | 39.97B | | +15.99% | 38.97B | | +5.14% | 33.12B | | +5.29% | 19.41B | | +12.32% | 16.73B | | +8.31% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|